University of Colorado Boulder 1002174424

E-Cadherin (24E10) Rabbit mAb; ZEB1 (D80D3) Rabbit mAb; Vimentin (D21H3) XP Rabbit mAb; ID1 (F2M1J) Rabbit mAb

On August 11, 2025, the University of Colorado Boulder, a state government entity located in Colorado, awarded a contract to Cell Signaling Technology Inc for multiple monoclonal antibodies, including E-Cadherin, ZEB1, Vimentin, and ID1. The total obligation amount was $1,349.43, covering four line items with individual prices of $315.27, $315.27, $345.03, and $373.86 respectively. The purchase was made as a single transaction from a single vendor, with no specified contract end date, and is classified as a state award.

Description

E-Cadherin (24E10) Rabbit mAb; ZEB1 (D80D3) Rabbit mAb; Vimentin (D21H3) XP Rabbit mAb; ID1 (F2M1J) Rabbit mAb